A scoring system to predict the most common type of primary liver cancer: hepatocellular carcinoma
8 May 2018
The “Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B” was achieved and validated through analyses of population-wide data from Taiwan and Hong Kong. Based on simple and easily available information, the CAMD (i.e. cirrhosis, age, male sex, and diabetes mellitus) score can predict hepatocellular carcinoma, the most common type of primary liver cancer, during oral antiviral therapy in patients with chronic hepatitis B (J Hepatol. 2018 Mar 16. pii: S0168-8278(18)30170-3. doi: 10.1016/j.jhep.2018.02.032. [Epub ahead of print]).
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Grace Wong. Prof Wong is an expert in non-invasive assessment of liver fibrosis, hepatocellular carcinoma, and chronic viral hepatitis; she has published over 160 articles in peer-reviewed journals.